Kinetic behavior and reversible inhibition of monoamine oxidases--enzymes that many want dead. 2011

Keith F Tipton, and Gavin P Davey, and Andrew G McDonald
Department of Biochemistry, Trinity College, Dublin, Ireland.

Monoamine oxidase (MAO) inhibitors have proven to be valuable tools in pharmacology and therapeutics. This account concerns the behavior of the different types of reversible inhibitor and how an understanding of the kinetic mechanisms of MAO may help in their design.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008995 Monoamine Oxidase An enzyme that catalyzes the oxidative deamination of naturally occurring monoamines. It is a flavin-containing enzyme that is localized in mitochondrial membranes, whether in nerve terminals, the liver, or other organs. Monoamine oxidase is important in regulating the metabolic degradation of catecholamines and serotonin in neural or target tissues. Hepatic monoamine oxidase has a crucial defensive role in inactivating circulating monoamines or those, such as tyramine, that originate in the gut and are absorbed into the portal circulation. (From Goodman and Gilman's, The Pharmacological Basis of Therapeutics, 8th ed, p415) EC 1.4.3.4. Amine Oxidase (Flavin-Containing),MAO,MAO-A,MAO-B,Monoamine Oxidase A,Monoamine Oxidase B,Type A Monoamine Oxidase,Type B Monoamine Oxidase,Tyramine Oxidase,MAO A,MAO B,Oxidase, Monoamine,Oxidase, Tyramine
D008996 Monoamine Oxidase Inhibitors A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414) MAO Inhibitor,MAO Inhibitors,Reversible Inhibitors of Monoamine Oxidase,Monoamine Oxidase Inhibitor,RIMA (Reversible Inhibitor of Monoamine Oxidase A),Reversible Inhibitor of Monoamine Oxidase,Inhibitor, MAO,Inhibitor, Monoamine Oxidase,Inhibitors, MAO,Inhibitors, Monoamine Oxidase
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Keith F Tipton, and Gavin P Davey, and Andrew G McDonald
February 1991, Biochemical Society transactions,
Keith F Tipton, and Gavin P Davey, and Andrew G McDonald
November 1998, Biochemical Society transactions,
Keith F Tipton, and Gavin P Davey, and Andrew G McDonald
January 1998, Journal of neural transmission. Supplementum,
Keith F Tipton, and Gavin P Davey, and Andrew G McDonald
August 2001, The EMBO journal,
Keith F Tipton, and Gavin P Davey, and Andrew G McDonald
November 1965, Journal of medicinal chemistry,
Keith F Tipton, and Gavin P Davey, and Andrew G McDonald
March 1985, Biochemical and biophysical research communications,
Keith F Tipton, and Gavin P Davey, and Andrew G McDonald
May 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
Keith F Tipton, and Gavin P Davey, and Andrew G McDonald
July 1974, Biochemistry,
Keith F Tipton, and Gavin P Davey, and Andrew G McDonald
January 1982, Vestnik Akademii meditsinskikh nauk SSSR,
Keith F Tipton, and Gavin P Davey, and Andrew G McDonald
March 2002, Biochemical pharmacology,
Copied contents to your clipboard!